Cancer care is complex. For patients prescribed oral oncolytics, managing side effects, staying on schedule, and coordinating care can be overwhelming. These challenges often lead to missed doses, therapy interruptions, and avoidable hospital visits.
This white paper explores how pharmacist-led clinical interventions within integrated health system specialty pharmacy (HSSP) models are helping patients stay on therapy, avoid complications, and improve their quality of life.
Download the white paper to learn how:
Pharmacist-led interventions reduce emergency visits and hospitalizations
Proactive patient engagement improves adherence and satisfaction
Health systems achieved over $75 million dollars in cost avoidance in three years
92 percent of patients stayed on therapy, and 93 percent reported no missed school or workdays
This is more than a care model. It is a proven approach that puts patients first and delivers measurable results.